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Dendritic cells (DC) are antigen presenting cells (APC) with the unique ability to initiate an
immune response. Immature DC are localized in peripheral tissues where they exert a sentinel
function for incoming antigens (Ag). After Ag capture and exposure to inflammatory stimuli
DC undergo maturation and migrate to regional lymph nodes where the presentation of anti-
genic peptides to T lymphocytes takes place. Thus their correct functioning as APC involves
localization in tissues and trafficking via the lymph or blood to lymphoid organs. In the
present study we have investigated the ability of DC to interact in vitro with human vascular
endothelial cells (EC) and extracellular matrix (ECM). DC are differentiated from monocytes
by in vitro exposure to GM-CSF and IL-13 for 7 days. In adhesion assays a considerable pro-
portion of I3C binds to resting EC monolayers and this adhesion is inhibited by anti-CD a
and CDllb, but not anti-CDllc mAbs. Binding to a natural ECM, derived from cultured EC
involves VLA-4 and VLA-5 integrins. In a transmigration assay, 10 % of input cells are able
to cross the EC monolayer in the absence of exogenous stimuli. The amount of DC transmi-
grated through a monolayer of EC was increased of 2-3 fold by C-C chemokines RANTES,
MIP1, and MIP-113. Most importantly, in view of the trafficking pattern of these cells, a sig-
nificant proportion of DC can migrate in a reverse transmigration assay, i.e. across the
endothelial basement membrane and subsequently, across endothelial cells. Upon exposure to
immune or inflammatory signals peripheral DC undergo maturation and migration to lym-
phoid organs. Functional maturation is associated with loss of responsiveness to chemokines
present at sites of inflammation (e.g. MIPlc, MIPll3 and RANTES) and acquisition of a
receptor repertoire which renders these cells responsive to signals which guide their localiza-
tion in lymphoid organs (e.g. MIP313). A better understanding of the molecular basis of DC
trafficking may provide molecular and conceptual tools to direct and modulate DC localiza-
tion as a strategy to upregulate and orient specific immunity.
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cells
Abbreviations: DC, dendritic cells, mono-DC, DC derived from monocytes, CD34-DC, DC derived from
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RANTES, regulated on activation normal T cell expressed and secreted, SLC, secondary lymphoid tissue
chemokine
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INTRODUCTION
Dendritic cells (DC) are professional antigen present-
ing cells (APC) which play a key role in the initiation
of an immune response. DC precursors migrate from
the bone marrow via the blood stream to non lym-
phoid tissues to become resident immature DC (Stein-
man, 1991; Hart, 1997; Banchereau et al. 1998;
Sallusto et al. 1999). DC at the immature stage of dif-
ferentiation efficiently take up and process incoming
antigens (Ag). Upon exposure to immune or inflam-
matory signals peripheral DC undergo maturation and
migrate as veiled cells to the T cell areas of lymph
nodes (Steinman, 1991; Austyn, 1996; Hart, 1997;
Banchereau et al. 1998; Sallusto et al. 1999).
This trafficking of DC to lymph nodes is critical to
their overall function as APC, in fact it is established
that surgical removal of afferent lymphatic vessels
prevents sensitization to skin transplants or to contact
allergens (Frey et al. 1957; Barker et al. 1968). Dur-
ing their migration DC undergo phenotypical and
functional maturation. They stop capturing antigens
and upregulate the expression of co-stimulatory mole-
cules (CD54, CD58, CD80, and CD86). After reach-
ing the lymph node stabcapsular sinus, DC migrate to
the T cell areas. These DC, identified as interdigitat-
ing DC, have a strong ability to present the antigen to
naive T lymphocytes. The homing to lymphoid
organs and the activation of T cells is apparently the
final goal ofDC biological program since, very likely,
they undergo apoptosis within the T cell areas.
DC have long been recognized as highly motile
cells. In vivo studies have demonstrated that DC use
specific pathways of tissue trafficking. Application of
a fluorescent marker to skin induce migration of
Langerhans cells (LC) and a day later fluorescent LC
are found in the draining lymph nodes (Macatonia et
al. 1987). It has also been described that inhaled path-
ogens induce a very rapid mobilization of DC in the
airway epithelium (McWilliam et al. 1994; McWil-
liam et al. 1996). After i.v. injection of inert particles,
cells with DC characteristic are recruited to the
hepatic sinusoid and then translocate to the hepatic
lymph (Matsuno et al. 1996). Inflammatory signals
exert a dual influence on the migration of DC. On the
one hand increased recruitment of blood precursors is
observed at sites of infection or inflammation. On the
other, systemic treatment with LPS provokes a mas-
sive egress of DC from several organs, such as skin,
heart, kidney, intestine and cause DC migration from
marginal zone of the spleen to T cell areas (Macpher-
son et al. 1995; Roake et al. 1995; De Smedt et al.
1996).
The complex trafficking ofDC involves their inter-
action with the endothelial linings and with extracel-
lular matrix (ECM). In this study we will discuss how
adhesion molecules and chemokines regulate the
interaction ofDC with endothelial cells (EC) and with
ECM, and will analyze which chemotactic signals
regulate the migratory behaviour of DC at different
stages of maturation.
RESULTS
In vitro adhesion ofDC to EC monolayers
and ECM
DC were differentiated in vitro from highly purified
human monocytes in the presence ofGM-CSF+ IL-13
for 7 days. As previously reported these cultured DC
expressed high levels of CDla, MHC Class II and
CD86 and were strong stimulators of allogeneic T
lymphocyte proliferation in Mixed Leukocyte Reac-
tion (MLR) (Piemonti et al. 1995; Sozzani et al.
1997). In previous experiments we showed that DC
expressed high levels of 2 integrins and, among 1
integrins, CD49d and CD49e (VLA-4 and VLA-5).
All the cells stained positive for CD61 ([3), for CD31
(PECAM-1) and were negative for CD62L (L-selec-
tin, data not shown) (D’Amico et al. 1998).
The identification of adhesion molecules involved
in the binding to EC and to ECM was performed by
using functional blocking mAb. A representative
experiment is shown in Fig. 1: anti-CDlla,
anti-CD lb and anti-CD18 mAbs partially inhibited
adhesion (52%, 64%, and 68% respectively, while
anti-CD c, although expressed to a very high extent
on DC, was not involved in binding to endotheliumDC TRAFFICKING THROUGH EC AND ECM 145
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FIGURE Molecules involved in the adhesion of DC to resting EC (A) and to EC-derived matrix (ECM) (B). DC were differentiated from
blood monocytes by 7-day culture with 50 ng/ml GM-CSF and 10 ng/ml IL-13.51Cr_labeled DC were preincubated for 20 min at room tem-
perature with the indicated mAb, thereafter DC were co-incubated for lh at 37C. Results are expressed as % of adherent cells, mean+SE of
three replicates. ECM was prepared by culturing a monolayer of EC on policarbonate filters for at least 5 days; EC were then stripped by a
NH4OH + Triton x-100 solution for 30 sec. Statistically slgmficant at p<0.01 vs medium control
(Fig. 1A). These results were confirmed in a larger
series of experiments (mean inhibition with
anti-CD18, 61+_4% mean+_SE of 7 experiments).
Binding of DC to a natural ECM, derived from cul-
tured EC, was usually higher than to EC monolayers:
52+6% of input cells compared to 17+4 % (mean+SE
of 6-8 experiments). Anti-VLA-4+VLA-5 mAbs or
anti-CD29 inhibited most of the binding (>75% inhi-
bition) while as expected- antiCD18 had no effect,
Fig. 1B).
Direct and reverse transendothelial migration
As mentioned above, blood DC precursors, like other
leukocytes, exit from the blood stream by interacting
with the endothelial cell barrier from the apical side.
However, when peripheral DC become activated, and
migrate from the tissue of residence to afferent lym-
phatics, they first interact with the basement mem-
brane of lymphatic or blood vessels and then with the
apical side. We therefore established an assay to
mimic both the apical/basal transmigration (direct) as
well as the basal/apical transmigration (reverse).
These methods were previously described in details
(Bianchi et al. 1993; D’Amico et al. 1998). As shown
in Fig. 2 DC effectively migrated through resting EC
monolayers in a direct transmigration assay (left
panel). The proportion of transmigrated cells corre-
sponds to 10.6+1.6% of input cells and to 33% of
adherent cells (mean+SE; n=6).
In the reverse transmigration assay, an upper filter
is coated with ECM and a lower filter is coated with a
monolayer of EC, placed upside down. The mean
amount of transmigrated cells relative to input was146 GIANCARLO BIANCHI et al.
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FIGURE 2 Trans-endothelial migration of DC. In the direct transmigration (A), a porous policarbonate filter was coated with a monolayer of
EC and placed in modified Boyden chamber. In the reverse transmigration (B) a double filter system was used. The upper filter was coated
51 with an ECM and the lowe, filter was coated with a monolayer of EC placed upside down. -Cr-labeled DC were seeded in the upper com-
partment of the chamber and co-incubated with EC monolayer for lh at 37C. Results are expressed as % of adherent and transmigrated cells
mean_+SEM of three replicates
13___4% (n 4) which corresponds to 20.8% of adher-
ent cells. The reason for a lower proportion of trans-
migrated-over-adherent cells in the reverse assay
resides probably in the fact that the double filter is a
thicker barrier to cross.
Adhesion and transmigration of immature
and mature DC
Upon exposure to microbial products (e.g. LPS),
inflammatory cytokines (e.g. IL-1 and TNF) or
immune stimuli (e.g. CD40 ligation), peripheral DC
undergo maturation and migrate as veiled cells to the
T cell areas of lymph nodes (Steinman, 1991; Austyn,
1996; Hart, 1997; Banchereau et al. 1998; Sallusto et
al. 1999). DC at the two stages of differentiation dis-
play different functional activities: mature DC have
low Ag uptake but are potent APC, while immature
DC are poor APC but have a strong activity to uptake
and process Ags. As it is not clear the precise stage of
differentiation/maturation of the migrating cell, it was
of interest to compare the migratory ability of mature
and immature DC. Fig. 3 shows that mature DC
migrate with less efficiency through an endothelial
monolayer, compared to immature DC, while the
adhesive ability was similar. Overall the spontaneous
ability of mature DC to cross the endothelial barrier
was half that of immature cells.
Trans-endothelial migration in response
to chemokines
The above described lower migratory activity of
mature DC could be due to an unresponsiveness toDC TRAFFICKING THROUGH EC AND ECM 147
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FIGURE 3 Effect of maturation on DC trans-endothelial migration. To induce maturation, immature DC were incubated with CD40L-trans-
fected cells (CD40L) (5" ratio), for 48 h before being tested. 51Cr-labeled DC were seeded in the upper compartment. Radioactivity present
in the lower compartment was evaluated after incubation at 37C for h
chemotactic factors which are known to regulate the
directional migration of these cells and are produced
by EC (Sozzani et al. 1999; Sallusto et al. 1999). We
therefore tested mature and immature DC in a trans-
migration assay in the presence of chemokines. Fig. 4
shows that MIPlc, MIP3I and RANTES placed in
the lower compartment of the chemotactic chamber,
significantly attracted immature DC more than
medium control. Surprisingly, mature DC do not
respond any more to MIP-1 cz, RANTES and MIP-1
In marked contrast, the response to MIP3[ was much
higher than that of immature DC. These findings are
in line with the expression of chemokine receptors in
immature and mature DC, as recently reported (Dieu
et al. 1998; Sozzani et al. 1998; Sallusto et al. 1998;
Yoshida et al. 1997; Lin et al. 1998). In fact, as sum-
marized in Table I, maturation of DC is associated
with switch of chemokine receptor expression. Spe-
cifically, mature DC downregulate CCR1 and CCR5
(receptors for MIPla, MIPI and RANTES) and
upregulate CCR7 (MIP3[ and SLC).
Differentiation ofDC on ECM-conditioned tissue
culture plastic
As the stage of differentiation and maturation of DC
play such an important role in the functional activity
of DC, it was of interest to assess environmental fac-
tors which may modulate the in vitro differentiation
of monocytes into DC. We therefore asked the ques-
tion whether culture of monocytes on a substrate
other than plastic could favour, or inhibit, the process
of DC differentiation. To verify this, monocytes were
incubated on ECM-coated tissue culture plates or
standard plates. ECM was prepared as described
above, by stripping a monolayer of EC. Fig. 5 shows
that the phenotype of DC differentiated on148 GIANCARLO BIANCHI et al.
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FIGURE 4 Effect of chemoines on transendothelial migration of immature and CD40L-matured DC. Policarbonate transwell inserts were
coated with a monolayer of EC and chemoattractants (100ng/ml) were seeded in the lower compartment. 51-Cr labeled DC were placed in
the upper compartment and incubated for lh at 37C. * Statistically significant at p<0.01
ECM-coated plastic did not differ from that of stand-
ard DC cultures. Both cell types had high levels of
CD 1 a. The expression of the co-stimulatory molecule
CD86, which is low in immature DC, was also simi-
lar, indicating that the stage of differentiation/matura-
tion in the two culture systems was not significantly
different. Finally, also CD68, a marker highly
expressed in mature macrophages was similarly low,
suggesting that incubation on ECM does not favour
the differentiation of monocytes into macrophages.
DC cultured on ECM were also tested for their acces-
sory function in a MLR assay. These DC were high
APC for allogenic T cells, with no significant differ-
ence compared to standard DC (data not shown).
TABLE Switch of chemokine receptor expression during DC maturation
Receptors Immature D C Mature DC Ligands
CCR1 +
CCR5 +
CCR7 +/- +-I-
MIP-l,a RANTES MCP 2/3
MIP- a, MIP- , RANLES, MCP-2
MIP-3, SLC
a. MIP: macrophage inflammatory protein; RANTES: regulated on activation normal T cell expressed and secreted;MCP: monocyte
chemotactic protein; SLC: secondary lymphoid tissue chemokine.DC TRAFFICKING THROUGH EC AND ECM 149
DISCUSSION
Trafficking is a crucial component of the immunobi-
ology of DC. Technical improvements, including
appropriate culture techniques and the setting up of
convenient assays representative of different steps of
trafficking, have provided the tools to begin the dis-
section of the molecular basis of this complex series
of events.
We have shown that even in the absence of exoge-
nously applied stimuli, DC bind to EC and more con-
sistently to ECM and efficiently cross these barriers
(D’Amico et al. 1998). Similar results on transend-
othelial migration of human monocyte-derived DC
were reported (Jancic et al. 1998; Lin et al. 1998).
Interestingly, we also showed that DC perform a
reverse transmigration, i.e. from the basal to the api-
cal direction, a situation that is most likely to occur in
vivo when maturing DC migrate fromperipheral tis-
sues to regional lymph nodes (D’Amico et al. 1998).
Another model of reverse transmigration was
described by Muller et al with blood monocytes,
which are DC precursors. In this assay EC were
grown on collagen type I. Blood monocytes were
allowed to penetrate into the collagen gel beneath the
EC monolayer and, subsequently, most of them, cross
again the overlying endothelium in 24-48 h. A major
issue raised by these Authors is that reverse transmi-
gration combined with phagocytosis of particles in
the sub-endothelial collagen induced maturation of
DC (Randolph et al. 1998). Binding to collagen type
but not fibronectin- stimulated maturation of DC,
most likely by increasing the TNF production by DC
themselves (Brand et al. 1998). In contrast, we did not
find any significant positive or negative effect of
ECM on the differentiatation of monocytes into DC.
Chemokines have emerged as major regulators of
DC migration in vitro and in vivo (Baggiolini et al.
1997; Rollins, 1997; Mantovani et al. 1998). We and
others have previously reported that DC respond to a
defined set of inflammatory chemokines, including
MIPlo and MIPI, MCP3, RANTES, MDC and
MIP3 (Sozzani et al. 1995; Sozzani et al. 1997;
Godiska et al. 1997; Power et al. 1997; Greaves et al.
1997). More recently, it has become clear that only
immature cells are responsive to the above panel of
chemokines. In fact, maturation of DC is associated
with a switch of chemokine receptor expression on
the cell membrane. Downregulation of CCR1 and
CCR5, and of CCR6 on CD34-derived DC, explains
this unresponsiveness. Moreover, upregulation of
CCR7 explains the increased response to its ligands
MIP3b and SLC (Dieu et al. 1998; Sozzani et al.
1998; Sallusto et al. 1998; Yoshida et al. 1997; Lin et
al. 1998). These results have been obtained both in
classical chemotaxis assays as well as in transend-
othelial migration assays (Sozzani et al. 1998; Lin et
al. 1998). Overall these results suggest that the unre-
sponsiveness to inducible chemokines (MIPlo.
MIPI, RANTES etc) usually present at the inflam-
matory site, may favour the release of DC from
peripheral tissues and their floating towards lymph
nodes. Concomitantly, the increased response to
MIP3[ and SLC, two chemokines constitutively
expressed in secondary lymphoid organs (Willimann
et al. 1998; Ngo et al. 1998; Dieu et al. 1998), will
guide DC directly at the right place (Sozzani et al.
1999; Cyster, 1999; Sallusto et al. 1999).
The understanding of the role of chemokines in DC
trafficking in vivo has received great advantage from
the use of gene modified animals. Mice homozygous
for an autosomal recessive mutation, paucity of
lymph node T cells (plt), fail to express SLC and have
reduced MIP-3. DC from these mice fail to accumu-
late in the spleen and T cell areas of lymph nodes
(Gunn et al. 1999). Expression of SLC and MIP3 is
also reduced in mice deficient ofTNF or lymphotoxin
o/[. These mice show alteration in the architecture of
lymphoid organs and lymphocytes fail to adequately
compartimentalize in B and T cell areas. Lymph
nodes from lymphotoxin o/[-deficient mice also have
reduced numbers of DC (Ngo et al. 1999), and TNF
receptor 1-deficient mice have depressed migration of
LC to lymph nodes (Wang et al. 1997). A role for
CCR7 and its ligands in DC migration from
TNF-treated skin explants was also recently indicated
by the use of blocking antibodies (Saeki et al. 1999).
These findings indicate that a "tonic" production of
lymphotoxin o/ and TNF very likely regulate the
production of chemokines by stromal cells. These150 GIANCARLO BIANCHI et al.
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FIGURE 5 Flow cytometric analysis of membrane molecules expressed by DC differentiated on ECM-coated tissue culture plates. Mono-
cytes were cultured with 50 ng/ml GM-CSF and 20 ng/ml IL-13 for 7 days on standard tissue culture plates or on ECM-coated plates pre-
pared by stripping a monolayer of EC (see M&M). Cells were labeled with the designed mAb and then with FITC-labelled goat anti
mouse-lg
chemokines, only apparently produced in a constitu-
tive way, are crucial for the recruitment of lymphoid
cells and APC from the periphery to the lymph node.
DC are considered promising tools and targets of
immunotherapeutic strategies; a better understanding
of the molecular basis of DC trafficking may provide
molecular and conceptual tools to direct and modulate
DC traffic as a strategy to upregulate and orient spe-
cific immunity.
MATERIALS AND METHODS
Culture media and reagents
The following reagents were used for separation of
effector cells, cell culture and experimental assays:
pyrogen-free saline for clinical use and distilled water
(Bieffe, Sondrio, Italy); medium RPMI 1640 (10X
concentrated, Biochrom KG, Berlin, Germany);
medium 199 (Gibco, Paisley, UK); glutamine
(Gibco); penicillin and streptomicin (Gibco); asepti-
cally collected FCS (Hyclone, Logan, UT). The rou-
tinely employed tissue culture medium was RPMI
1640 with 2 mM glutamine, 50 mg/ml of gentamicin,
10% FCS.
Cytokines
Human recombinant GM-CSF, was a generous gift
from Novartis (Basel, Switzerland). Human recom-
binant IL-13 was a kind gift from Dr. A. Minty
(Sanofi Elf Bio Recherches, Lab6ge, France). Human
MIP-I, MIP-3 and RANTES, were from Pepro-
Tech Inc. (Rocky Hill, NJ, USA). Cytokines were
endotoxin free as assessed by Limulus Amebocyte
assay. Lipopolysaccharide (LPS; E. coli 055:B5) was
from Sigma (St. Louis, MO).DC TRAFFICKING THROUGH EC AND ECM 151
Preparation ofDC cultures
DC were differentiated in vitro as previously
described (Sozzani et al. 1995; Piemonti et al. 1995).
Highly enriched blood monocytes (> 95% CD14+)
were obtained from buffy coats by Ficoll and Percoll
gradients and purified by panning on CD6-coated
plastic dishes. Monocytes were cultured for 7 days at
1 106/ml in 6-well multiwell tissue culture plates
(Falcon, Becton Dickinson, New Jersey) in RPMI
(Biochrom, Berlin, FRG) 10% FCS (Hyclone, Logan,
UT) supplemented with 50 ng/ml GM-CSF and 20
ng/ml IL-13. We previously described that mono-
cyte-derived DC generated in the presence of
GM-CSF+IL-13 are morphologically and function-
ally identical to DC cultured with GM-CSF+IL-4
(Sozzani et al. 1995; Piemonti et al. 1995). Where
specified, DC were further cultured in the presence of
10 ng/ml LPS for 48 hours or co-cultured with J558L
cells transfected with the gene encoding CD40L
(Cella et al. 1996) (kindly provided by Dr. Peter Lane,
Basel Institute for Immunology, Switzerland). DC
cultured with LPS or activated by CD40 ligation for
48 hours expressed typical maturation markers and
high APC activity. For instance, after CD40L activa-
tion, DC were >70% CD83+: > 70% CD80+; MHC
class II bright (mean channel fluorescence > 900);
and highly effective in MLR (e.g. at 3% APC T cell
ratio, 3HTdr uptake was > 70,000 cpm; S.I. >35). Pre-
liminary experiments confirmed that incubation of
DC with the J558 mock cell line did not induce cell
maturation.
Monoclonal antibodies
The following mAbs were used: L243 (IgG2a, anti
MHC class II) purchased from ATCC (Rockville,
MD, USA); NA 1/34 (IgG2a, anti CDla) Dako Den-
mark); TS1/22 (IgG1, anti CDlla) and TS1/18 (IgG1,
anti CD18) from ATCC (Rockville, MD, USA);; 44a
(IgG2a, anti CD1 lb) was a kind gift of Dr. R. Todd
(Ann Arbor, MI,USA); L29 (IgG1 anti CD lc) was a
kind gift of Dr. L. Lanier (DNAX Palo Alto, CA,
USA); HP2/1 (IgG 1 anti-VLA4 was a kind gift of Dr.
E Sanchez-Madrid (University of Madrid, Spain);
M-A251 (IgG1 anti-CD25), IT2.2 (IgG2b anti-CD86)
and IIAI(IgG1 anti VLA5) were from Pharmingen-
Becton Dickinson, (NJ,USA). For FACS Analysis,
cell staining with primary mAb was followed by
FITC-conjugated affinity purified, isotype-specific
goat anti-mouse antibodies (Techno-Genetics).
Results are expressed as % of positive cells and as rel-
ative fluorescence intensity (RFI), calculated accord-
ing to the formula: RFI=mean fluorescence
(sample)-mean fluorescence (control) / mean fluores-
cence (control).
In adhesion or transmigration assays, optimally
diluted mAb were preincubated with the cells for
20 min before plating; medium control contained an
isotype-matched irrelevant mAb.
Preparation of endothelial cells (EC)
Human EC were obtained from umbilical vein and
cultured as previously described (Sironi et al. 1989).
Routinely, we used confluent cells (105/cm2 culture
well) between the first and fourth passage maintained
in 199 medium with 20% bovine serum (Hyclone
Lab.) supplemented with endothelial cell growth sup-
plement (50 tg/ml, Collaborative Research Inc., Lex-
ington, MA, USA) and heparin (100 tg/ml, Sigma
Chemical Co., St. Louis, MO, USA). The purity of
EC cultures was checked by expression of von Wille-
brand factor and found to be >99% positive.
Preparation of extra-cellular matrix (ECM)
The ECM was prepared by growing a monolayer of
EC on filters for at least 5 days; EC were then
stripped away by a short treatment with a 20 mM
NH4OH solution + 0.5% Triton X-100 for 30 sec.
Adhesion assay
Adhesion ofDC to endothelial cells (EC) was studied
as described previously (Allavena et al. 1991). EC
were grown to confluence in flat-bottomed 48-well
trays. 51Cr-labeled DC (Amersham, UK) were
co-incubated with EC monolayers at 37C for lh. At152 GIANCARLO BIANCHI et al.
the end non-adherent cells were washed away and
adherent cells were solubilized with 0.1 ml of 0.1%
SDS and radioactivity was counted in a gamma coun-
ter. Results represent % of adherent cells + SD of
three replicates/group.
Transmigration and reverse transmigration assay
This assay was performed as previously described
(Bianchi et al. 1993). In brief, EC were grown to con-
fluence on PVP-free polycarbonate filters (5 mm
pore) and mounted on modified Boyden chambers
over a nitrocellulose filter. 51Cr-labeled DC were
seeded in the upper compartment and co-incubated
with EC monolayers for lh at 37C. Non adherent
cells were gently washed away, the radioactivity
present in the double filter and in the lower compart-
ment were the transmigrated cells; the adherent cells
were considered to comprise both cells bound to EC
as well as those that had transmigrated.
In the reverse transmigration assay an upper poli-
carbonate filter was coated with ECM, and the lower
policarbonate filter was coated by a monolayer of EC,
placed upside down, and mounted in the Boyden
chamber. In this assay, the radioactivity present in the
lower compartment only accounted for the transmi-
grated cells. In some experiments policarbonate tran-
swell inserts (5mm pore, Corning, Costar,
Cambridge, MA,USA) were used. Inserts were coated
with EC monolayers; chemoattractants, usually
100ng/ml, were seeded in the lower compartmert.
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